Validation in Thermal Analysis.
Clasificación: | Libro Electrónico |
---|---|
Autor principal: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
[Place of publication not identified] :
Carl Hanser Verlag GmbH & Co. KG : Carl Hanser Verlag GmbH & Co. KG,
2022.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Intro
- List of Contributors
- Contents
- Introduction
- Part 1: Validation of Computerized Systems
- 1 Changes in Regulations and Regulatory Guidance Since the First Mettler-Toledo Edition
- 1.1 Data Integrity
- 1.1.1 Regulatory Authority Data Integrity Guidance Documents
- 1.1.2 Industry Data Integrity Guidance Documents
- 1.1.3 ALCOA+ Criteria for Integrity of Laboratory Data
- 1.1.4 Static and Dynamic Data
- 1.1.5 Data Integrity Guidance Summary
- 1.2 Updating EU Good Manufacturing Practice (GMP) Regulations
- 1.3 USP Analytical Instrument Qualification
- 1.4 GAMP 5 Guide and Validation of Laboratory Systems Good Practice Guide
- 1.5 Validation of Analytical Procedures
- 1.6 A Data Integrity Model
- 2 Instrument Qualification, Computerized System Validation and Method Validation
- 2.1 Terminology
- 2.1.1 What is a Computerized System?
- 2.1.2 Instrument Calibration and Adjustment
- 2.1.3 Analytical Instrument Qualification (AIQ)
- 2.1.4 Computerized System Validation (CSV)
- 2.1.5 Reconciling Analytical Instrument Qualification and Computerized System Validation
- 2.1.6 Different Aims of Computerized System Validation IQ and OQ
- 2.1.7 Future of the 4Qs Model
- 2.1.8 Analytical Method Validation (AMV)
- 2.1.9 AIQ, CSV and AMV Interrelationships
- 2.2 Apply Validated Methods Using Qualified Instrumentation
- 2.3 Distinguishing between Analytical Instrument Qualification and Method Validation
- 2.3.1 What is Done in AIQ and What is Done in AMV?
- 2.3.2 Impact of AIQ on Method Transfer
- 3 Regulatory Requirements for Computerized System Validation
- 3.1 Regulatory Agencies
- 3.2 Responsibility for Computerized System Validation
- 3.3 Regulations and Guidelines Impacting a Computerized System
- 3.3.1 FDA Good Manufacturing Practice (GMP) 21 CFR Part 211
- 3.3.2 Quality System Regulation for Medical Devices: 21 CFR Part 820
- 3.3.3 ICH Q7(R1): GMP for Active Pharmaceutical Ingredients
- 3.3.4 Electronic Records and Electronic Signatures: 21 CFR Part 11
- 3.3.5 European Union GMP Annex 11 for Computerized Systems
- 3.3.6 FDA Guidance on General Principles of Software Validation
- 3.3.7 FDA Guidance on Computerized Systems Used in Clinical Investigations
- 3.3.8 PIC/S Guidance for Computerized Systems
- 3.3.9 Summary of Regulatory Requirements
- 3.4 ISO 17025: 2017
- 3.5 Warning Letters and Observations Involving Data Integrity and Computerized System
- 3.5.1 Quality Management System Failures
- 3.5.2 Instrument Citations
- 3.5.3 Citations for Lack of Laboratory Controls
- 3.5.4 Failure to Have Complete Laboratory Records
- 3.5.5 Key Data Integrity and CSV Inspection Learning Points
- 4 Computerized System Validation
- 4.1 Why Bother to Validate Your Computerized System?
- 4.2 What is Computerized System Validation (CSV)?
- 4.2.1 Principles of Computerized System Validation
- 4.2.2 Computerized System Validation Assumptions and Misconceptions